| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |